PMC Links for Books (Select 2824162) - PMC

Result Filters

Links from Books

Items: 20

Select item 82158881.

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

D.F. Bajorin, J.A. Witjes, J.E. Gschwend, M. Schenker, B.P. Valderrama, Y. Tomita, A. Bamias, T. Lebret, S.F. Shariat, S.H. Park, D. Ye, M. Agerbaek, D. Enting, R. McDermott, P. Gajate, A. Peer, M.I. Milowsky, A. Nosov, J. Neif Antonio, Jr., K. Tupikowski, L. Toms, B.S. Fischer, A. Qureshi, S. Collette, K. Unsal-Kacmaz, E. Broughton, D. Zardavas, H.B. Koon, M.D. Galsky

N Engl J Med. Author manuscript; available in PMC 2021 Dec 3.

Published in final edited form as: N Engl J Med. 2021 Jun 3; 384(22): 2102–2114. doi: 10.1056/NEJMoa2034442

PMCID:: PMC8215888

Abstract Article PDF–921K

Select item 79847272.

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Manish R Patel, John Ellerton, Jeffrey R Infante, Manish Agrawal, Michael Gordon, Raid Aljumaily, Carolyn D Britten, Luc Dirix, Keun-Wook Lee, Mathew Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Arnold B Gelb, Junyuan Xiong, Galit Rosen, James L Gulley, Andrea B Apolo

Lancet Oncol. Author manuscript; available in PMC 2021 Mar 22.

Published in final edited form as: Lancet Oncol. 2018 Jan; 19(1): 51–64. Published online 2017 Dec 5. doi: 10.1016/S1470-2045(17)30900-2

PMCID:: PMC7984727

Abstract Article PDF–1.4M

Select item 69468803.

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P Petrylak, Ronald de Wit, Kim N Chi, Alexandra Drakaki, Cora N Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed A Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y Yu, Michiel S van der Heijden, Nobuaki Matsubara, Boris Alekseev, Andrea Necchi, Lajos Géczi, Yen-Chuan Ou, Hasan Senol Coskun, Wen-Pin Su, Jens Bedke, Georgios Gakis, Ivor J Percent, Jae-Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier Garcia del Muro, Alejo Rodriguez-Vida, Irfan Cicin, Hakan Harputluoglu, Scott T Tagawa, Ulka Vaishampayan, Jeanny B Aragon-Ching, Oday Hamid, Astra M Liepa, Sameera Wijayawardana, Francesca Russo, Richard A Walgren, Annamaria H Zimmermann, Rebecca R Hozak, Katherine M Bell-McGuinn, Thomas Powles, RANGE study investigators

Lancet Oncol. Author manuscript; available in PMC 2021 Jan 1.

Published in final edited form as: Lancet Oncol. 2020 Jan; 21(1): 105–120. Published online 2019 Nov 18. doi: 10.1016/S1470-2045(19)30668-0

PMCID:: PMC6946880

Abstract Article PDF–872K

Select item 67848504.

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

Jonathan E. Rosenberg, Peter H. O’Donnell, Arjun V. Balar, Bradley A. McGregor, Elisabeth I. Heath, Evan Y. Yu, Matthew D. Galsky, Noah M. Hahn, Elaina M. Gartner, Juan M. Pinelli, Shang-Ying Liang, Amal Melhem-Bertrandt, Daniel P. Petrylak

J Clin Oncol. 2019 Oct 10; 37(29): 2592–2600. Published online 2019 Jul 29. doi: 10.1200/JCO.19.01140

PMCID:: PMC6784850

Abstract Article PDF–1.2M

Select item 58242885.

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study

Thomas Powles, Peter H. O'Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher J. Hoimes, Jae Lyun Lee, Michael Ong, Srikala S. Sridhar, Nicholas J. Vogelzang, Mayer N. Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok K. Gupta, Yong Ben, Noah M. Hahn

JAMA Oncol. 2017 Sep; 3(9): e172411. Published online 2017 Aug 17. doi: 10.1001/jamaoncol.2017.2411

PMCID:: PMC5824288

Abstract Article

Select item 56732526.

Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive-Stage Small Cell Lung Cancer, N0423

Cheng E. Chee, James R. Jett, Albert M. Bernath, Jr, Nathan R. Foster, Garth D. Nelson, Julian Molina, Daniel A. Nikcevich, Preston D. Steen, Patrick J. Flynn, Kendrith M. Rowland, Jr

Cancer. Author manuscript; available in PMC 2017 Nov 6.

Published in final edited form as: Cancer. 2010 May 15; 116(10): 2382–2389. doi: 10.1002/cncr.24967

PMCID:: PMC5673252

Abstract Article PDF–137K

Select item 56480547.

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial

Prof. Padmanee Sharma, Margaret K Callahan, Petri Bono, Joseph Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi N Pillai, Patrick A Ott, Prof. Filippo de Braud, Prof. Michael Morse, Dung T Le, Dirk Jaeger, Emily Chan, Chris Harbison, Chen-Sheng Lin, Marina Tschaika, Alex Azrilevich, Jonathan E Rosenberg

Lancet Oncol. Author manuscript; available in PMC 2017 Nov 1.

Published in final edited form as: Lancet Oncol. 2016 Nov; 17(11): 1590–1598. Published online 2016 Oct 9. doi: 10.1016/S1470-2045(16)30496-X

PMCID:: PMC5648054

Abstract Article PDF–1023K

Select item 56354248.

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

J. Bellmunt, R. de Wit, D.J. Vaughn, Y. Fradet, J.-L. Lee, L. Fong, N.J. Vogelzang, M.A. Climent, D.P. Petrylak, T.K. Choueiri, A. Necchi, W. Gerritsen, H. Gurney, D.I. Quinn, S. Culine, C.N. Sternberg, Y. Mai, C.H. Poehlein, R.F. Perini, D.F. Bajorin

N Engl J Med. Author manuscript; available in PMC 2017 Oct 11.

Published in final edited form as: N Engl J Med. 2017 Mar 16; 376(11): 1015–1026. Published online 2017 Feb 17. doi: 10.1056/NEJMoa1613683

PMCID:: PMC5635424

Abstract Article PDF–781K

Select item 55686329.

Atezolizumab as first-line therapy in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, Thomas Powles, Daniel P Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman-Censits, Jose Luis Perez-Gracia, Nancy A Dawson, Michiel S van der Heijden, Robert Dreicer, Sandy Srinivas, Margitta M Retz, Richard W Joseph, Alexandra Drakaki, Ulka N Vaishampayan, Srikala S Sridhar, David I Quinn, Ignacio Durán, David R Shaffer, Bernhard J Eigl, Petros D Grivas, Evan Y Yu, Shi Li, Edward E Kadel, III, Zachary Boyd, Richard Bourgon, Priti S Hegde, Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O Abidoye, Gregg D Fine, Dean F Bajorin, for the IMvigor210 Study Group

Lancet. Author manuscript; available in PMC 2017 Aug 23.

Published in final edited form as: Lancet. 2017 Jan 7; 389(10064): 67–76. Published online 2016 Dec 8. doi: 10.1016/S0140-6736(16)32455-2

PMCID:: PMC5568632

Abstract Article PDF–1.0M

Select item 548024210.

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single arm, phase 2 trial

Jonathan E. Rosenberg, Jean Hoffman-Censits, Tom Powles, Michiel S. van der Heijden, Arjun V. Balar, Andrea Necchi, Nancy Dawson, Peter H. O’Donnell, Ani Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta M. Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, Jose Luis Perez-Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale Abidoye, Gregg D. Fine, Robert Dreicer

Lancet. Author manuscript; available in PMC 2017 Jun 22.

Published in final edited form as: Lancet. 2016 May 7; 387(10031): 1909–1920. Published online 2016 Mar 4. doi: 10.1016/S0140-6736(16)00561-4

PMCID:: PMC5480242

Abstract Article PDF–913K

Select item 338844911.

Bladder cancer, a review of the environmental risk factors

Silvia Letašiová, Alžbeta Medveďová, Andrea Šovčíková, Mária Dušinská, Katarína Volkovová, Claudia Mosoiu, Alena Bartonová

Environ Health. 2012; 11(Suppl 1): S11. Published online 2012 Jun 28. doi: 10.1186/1476-069X-11-S1-S11

PMCID:: PMC3388449

Abstract Article PDF–220K

Select item 338401312.

Occupational cancer in Britain: Urinary tract cancers: bladder and kidney

Terry Brown, Rebecca Slack, Lesley Rushton, with the British Occupational Cancer Burden Study Group

Br J Cancer. 2012 Jun 19; 107(Suppl 1): S76–S84. Published online 2012 Jun 19. doi: 10.1038/bjc.2012.121

PMCID:: PMC3384013

Article PDF–423K

Select item 318370313.

Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder

Bedeir Ali-El-Dein, Mohammed S. Al-Marhoon, Mohamed Abdel-Latif, Ahmed Mesbah, Atallah A. Shaaban, Adel Nabeeh, El-Housseiny I. Ibrahiem

Urol Ann. 2011 Sep-Dec; 3(3): 127–132. doi: 10.4103/0974-7796.84960

PMCID:: PMC3183703

Abstract Article PDF–593K

Select item 310774014.

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

International Collaboration of Trialists, the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group, the Australian Bladder Cancer Study Group, the National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, Club Urologico Espanol de Tratamiento Oncologico Group

J Clin Oncol. 2011 Jun 1; 29(16): 2171–2177. Published online 2011 Apr 18. doi: 10.1200/JCO.2010.32.3139

PMCID:: PMC3107740

Abstract Article PDF–207K

Select item 310442515.

Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience

Venu Chalasani, Wassim Kassouf, Joseph L. Chin, Yves Fradet, Armen G. Aprikian, Adrian S. Fairey, Eric Estey, Louis Lacombe, Ricardo Rendon, David Bell, Ilias Cagiannos, Darrell Drachenberg, Jean-Baptiste Lattouf, Jonathan I. Izawa

Can Urol Assoc J. 2011 Apr; 5(2): 83–87. doi: 10.5489/cuaj.10040

PMCID:: PMC3104425

Abstract Article PDF–1020K

Select item 279295616.

Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986

Maria De Santis, Joaquim Bellmunt, Graham Mead, J. Martijn Kerst, Michael Leahy, Pablo Maroto, Iwona Skoneczna, Sandrine Marreaud, Ronald de Wit, Richard Sylvester

J Clin Oncol. 2009 Nov 20; 27(33): 5634–5639. Published online 2009 Sep 28. doi: 10.1200/JCO.2008.21.4924